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ABSTRACT
Background: Bodies of evidences have suggested that upper and lower airways are intricately intercon-
nected with each other in patients with allergic airways diseases, however, few data are available concerning
the impact of allergic rhinitis on self-assessed asthma condition and treatment satisfaction. The present study
was conducted to clarify the association between nasal condition and self-assessment of asthma control and
treatment satisfaction.
Methods: Adult patients with asthma were consecutively recruited for a systematic self-administered ques-
tionnaire to obtain information on nasal condition, self-perceived condition of asthma, and asthma treatment
satisfaction.
Results: 3,140 adult patients with asthma completed the questionnaire, and of these 634 patients (mean age:
53.1, 389 female) had physician-diagnosed allergic rhinitis. There were significant correlations between nasal
symptoms (sneeze, rhinorrhea, nasal obstruction) and self-perceived asthma condition (limited daily activity,
wheeze, dyspneachest tightness, cough, sputum, sleep disturbance, overall asthma condition). Patients who
considered their overall nasal condition as unfavorable or bad were more likely than those who considered their
condition as good or favorable to be dissatisfied with asthma treatment (p<0.01).
Conclusions: Nasal condition is closely associated with self-assessed asthma condition and asthma treat-
ment satisfaction. Controlling allergic rhinitis is critical to attain optimal management of asthma in patients com-
plicated by allergic rhinitis.
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INTRODUCTION
It is well documented that patients with asthma often
present with complications of allergic rhinitis and an
intimate association exists between the two condi-
tions.1 From a pathophysiological standpoint, for ex-
ample, nasal symptoms are correlated with nasal air-
flow, which in turn correlates with airflow limitation
in the lower airways as measured by FEV1.2 Patients
with asthma complicating allergic rhinitis were re-
ported to have more severe cough compared with
those with asthma alone.3 Treatment of allergic rhini-
tis has been shown to reduce subsequent asthma-
related emergency visits or hospitalizations.4 Pro-
posed links between the two diseases include aggra-
vation of asthma by mediators or inflammatory drips
produced by diseased nasal mucosa, a putative naso-
bronchial reflex, and mouth breathing resulting from
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nasal obstruction.5 Several mechanisms have been
proposed which link allergic rhinitis and asthma.
These facts and proposals indicate that asthma and al-
lergic rhinitis should be a united target for delivery of
optimal management. In addition to the clinical bur-
den, asthma and allergic rhinitis have a considerable
impact on quality of life. Poorly controlled disease
can result in not only physical but also emotional
strain in affected individuals.6 These disease control
problems perceived by patients are associated with
dissatisfaction to treatment,7 which in turn may result
in suboptimal outcome. However, data concerning
the associations of the self-assessed conditions of the
two diseases are surprisingly scarce. In the present
study we had an opportunity to gain insight into the
influence of nasal condition on self-assessment of dis-
ease control and treatment satisfaction in patients
with asthma complicated by allergic rhinitis.
METHODS
STUDY DESIGN
Data were obtained from 217 medical institutions par-
ticipating in a survey on bronchial asthma and aller-
gic rhinitis in eight prefectures of the Kyushu district
in Japan between May and December of 2003. Sub-
jects enrolled in the study were non-smoking con-
secutive adult patients with asthma complicated by al-
lergic rhinitis or with asthma alone who regularly vis-
ited one of the medical institutions participating to
the study. The study protocol was conducted in ac-
cordance with the Declaration of Helsinki and ap-
proved by the institutional ethical committees, and all
participants gave written informed consent. In the
survey a set of self-administered questionnaires was
completed twice one month apart by each participant
to obtain information on symptoms, self-assessed dis-
ease control and treatment satisfaction.
DIAGNOSIS OF ASTHMA AND ALLERGIC RHINI-
TIS
The diagnosis of asthma was established by revers-
ible airflow obstruction that occurs naturally or after
treatment, andor airway hyperresponsiveness.8 Se-
verity of asthma was judged based on current medica-
tions, symptoms and lung function.8 Patients were
considered as having allergic rhinitis if they pre-
sented with sneezing or nasal itching, watery nasal
discharge, and nasal obstruction, and either eosino-
philia in nasal discharge or positive results for the
skin prick test or elevated serum specific IgE for
common antigens (house dust and pollens).
QUESTIONNAIRE
The questionnaire items were as follows: items re-
lated to asthma (limitation in activity, wheeze, dysp-
neachest tightness, cough, sputum, sleep distur-
bance, overall self-assessed disease control, and cur-
rent treatment satisfaction); and items related to na-
sal symptoms (sneeze, rhinorrhea, nasal obstruction,
and overall self-assessment of disease condition).
Each nasal symptom was graded as follows: for
sneezing and rhinorrhea as measured by frequency
of nose blowing, none, 1 to 5 (mild), more than 6
times (moderate to severe) per day; for nasal obstruc-
tion, none, obstruction without air passage blockade
(mild), obstruction with occasional nasal air passage
blockade or more severe (moderate to severe).9
Symptoms of asthma (limited activity, wheeze, dysp-
neachest tightness, cough, sputum) were graded
based on average occurrence of the symptoms in a
week: none, 1 or 2, 3 or more days of the week. Self-
assessed overall disease condition was rated as excel-
lent, goodfair, or unfavorablebad. Asthma treat-
ment satisfaction was reported as satisfied, mostly
satisfied, neutraldissatisfied.
STATISTICAL ANALYSIS
All data analysis was performed by using SPSS 13.0J
for Windows software (SPSS Inc., Chicago, Illinois,
USA). Correlation between the parameters was ana-
lyzed using Spearman’s rank correlation. Compari-
sons of the proportion between groups were per-
formed by using the Kruskal-Wallis non-parametric
test. P values less than 0.05 were considered signifi-
cant.
RESULTS
PATIENT CHARACTERISTICS
The questionnaire was distributed to 3,270 patients
with asthma, and 3,140 (96.0%) including 1,289 men
(mean age: 65.3 year) completed the questionnaire.
634 of the total participants including 245 men (mean
age: 53.1 year) had physician-diagnosed allergic
rhinitis.
Demographics and current treatment for these pa-
tients are summarized in Table 1. There were 230
mild, 346 moderate, and 58 cases of severe asthmat-
ics. Mean age of patients with severe asthma (58.4
year) was higher than mild (50.4 year) and moderate
(53.9 year) counterparts. Inhaled corticosteroids
(ICS) were prescribed in 66% of patients with mild
asthma, and in most of the patients with moderate
and severe asthma. Mean dose of ICS was the high-
est in patients with severe asthma. Oral steroid was
used in 88% of patients with severe asthma, whereas
few patients with mild and moderate disease used
oral steroids. Theophylline, β-agonists (inhaled long
acting β-agonist or transdermally releasing formula)
and leukotriene receptor antagonists were more fre-
quently used in patients with moderate and severe
asthma than in those with mild disease. Nasal corti-
costeroids were prescribed in 24% of patients with se-
vere asthma and 11% of those with mild and moderate
asthma.
The proportions of the severity of nasal symptoms
in individuals based on the severity of asthma are
Asthma Control and Treatment Satisfaction in Allergic Rhinitis
Allergology International Vol 56, No4, 2007 www.jsaweb.jp 429
Table 1 Patient Characteristics
SevereModerateMildAsthma Severity
58 346  230  Number
28 (48.3)217 (62.7)144 (62.6)Female (%)
 58.4 53.9 50.4Age [year]
57 (98.3)342 (98.8)151 (65.6)ICS† (%)
791.4424.1204.6ICS† dose [μg]
49 (87.5) 5 (1.6) 2 (0.7)Oral corticosteroid (%)
26 (44.8)171 (49.4)20 (8.7)β2 agonist‡ (%)
44 (75.9)230 (66.5)46 (20)Theophyline (%)
30 (51.7)191 (55.2) 33 (14.3)Leukotriene modifier (%)
 9 (15.5) 64 (18.5) 49 (21.3)Anti-histamines (%)
14 (24.1) 37 (10.7) 26 (11.3)Nasal corticosteroid (%)
†ICS denotes inhaled corticosteroid
‡includes long-acting beta agonist and dermal patch
Table 2 Frequency of Nasal Symptoms in Subjects
Asthma Severity
severemoderatemild
26.927.9 25.7 none
Sneeze (%) 63.561.8 60.3 mild
 9.610.3 14.0 moderate/severe
17.616.3 17.1 none
Rhinorhea (%) 58.851.1 52.3 mild
23.532.6 30.6 moderate/severe
32.035.4 37.7 none
Nasal obstruciton (%) 44.036.4 33.0 mild
24.028.2 29.3 moderate/severe
 8.611.6 13.9 excelent
Overal nasal condition (%) 60.360.4 56.1 good/fair
31.028.0 30.0 neutral/unfavorable
summarized in Table 2. No significant differences in
the proportion of the severity of nasal symptoms were
noted among patients with differing severity of
asthma.
CORRELATION BETWEEN NASAL AND ASTHMA
SYMPTOMS
Correlation between symptoms of allergic rhinitis and
those of asthma based on self-assessment are pre-
sented in Table 3. Although the sizes of the associa-
tions based on the correlation coefficient were gener-
ally small,10 the severity of sneezing was significantly
correlated with all domains of severity of asthma
symptoms, i.e. activity limitation, wheeze, dyspnea
chest tightness, cough, sputum, sleep disturbance,
and overall asthma control. The severity of rhinor-
rhea was correlated with all but wheezing in the
morning and nighttime dyspnea. The severity of na-
sal obstruction was significantly correlated with all
symptoms except dyspneachest tightness in the
morning and daytime.
IMPACT OF NASAL CONDITION ON ASTHMA
TREATMENT SATISFACTION
When patients were divided in three groups based on
their satisfaction to current asthma treatment, there
was a significant difference in the proportion of self-
assessed overall nasal condition (p < 0.01) (Fig. 1).
433 patients were satisfied with their current asthma
treatment. The proportions of the overall nasal condi-
tion of those patients was as follows: 67 (15.5%) excel-
lent; 262 (60.5%) good to fair; 104 (24.0%) unfavorable
to bad. 106 patients were almost satisfied with treat-
ment, composed of 7 (6.6%) who had excellent nasal
condition, 64 (60.4%) with good to fair, and 35 (33.0%)
with unfavorable to bad. The figures for 95 patients
who were neutral to dissatisfied with asthma treat-
ment were 3 (3.2%), 47 (49.5%), and 45 (47.4%), re-
spectively.
DISCUSSION
The results of the present study demonstrated that
the severity of nasal symptoms (sneeze, rhinorrhea,
nasal obstruction) were significantly associated with
individual asthma symptoms, such as limited daily ac-
tivity, wheeze, dyspneachest tightness, cough, spu-
tum, sleep disturbance, and overall self-perceived
control of asthma. Furthermore, the results indicated
that overall nasal condition had a significant impact
on the patients’ asthma treatment satisfaction. The as-
sociation between nasal symptoms and asthma symp-
toms scores has been demonstrated.3 The results of
the present study were in line with those, and high-
lighted the association of individual nasal symptoms
with most of the individual asthma symptoms and
overall self-assessed asthma condition, although the
size of the associations based on the correlation coef-
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Fig. 1 Proportion of self-assessed overal nasal conditions 
(aqua, excelent; yelow, good/fair; red, unfavorable/bad) in 
subgroups based on satisfaction to treatment of asthma (up-
per, neutral to dissatisfied; middle, mostly satisfied; lower, 
satisfied). There was a statisticaly significant diference in 
the proportion. ( p＜0.001)
0% 20% 40% 60% 80% 100%
Satisfied
Mostly Satisfied
Neutral/Dissatisfied
Table 3 Corelations between Nasal and Asthma Symptoms†
Nasal Symptoms
Nasal ObstructionRhinorheaSneeze
0.14＊0.09＊＊0.15＊Activity limitation
0.15＊0.12＊0.16＊wheezeMorning
NS0.11＊＊0.14＊dyspnea
0.15＊NS0.11＊wheezeDaytime
NS0.10＊＊0.13＊dyspnea
0.15＊0.11＊0.20＊wheezeNightime
0.09＊＊NS0.17＊dyspnea
0.13＊0.14＊0.19＊Cough
0.14＊0.11＊0.11＊Sputum
0.14＊0.11＊0.14＊Sleep disturbance
0.15＊0.14＊0.15＊Overal asthma condition
†Corelations were analyzed by way of Spearman’s rank corelation.
＊p＜0.01, ＊＊p＜0.05
NS denotes not significant.
ficient were generally small10 in this data set.
Patient satisfaction is multifaceted, and involves
various aspects of medical management and patient-
doctor interactions.11 It has been documented that
problems in disease control is one of the contributors
to dissatisfaction with treatment in patients with
asthma.7 Since individual asthma symptoms and self-
perceived overall asthma conditions were signifi-
cantly associated with nasal symptoms, it is likely that
patients who were dissatisfied with asthma treatment
had a poorer nasal condition and vice versa. It is
known that treatment satisfaction is critical to main-
tain adherence to treatment.12 Therefore, it can be
speculated that controlling nasal symptoms is impor-
tant in attaining adherence to treatment.
The limitation of the present study is that unmeas-
ured factors might have influenced the observation.
For example, the recognition of the medications by
the patients was not evaluated in the study. Some
agents such as leukotriene receptor antagonists and
anti-histamines could be prescribed to treat either
asthma or allergic rhinitis, or both conditions. Patient
recognition of the target of their medications may af-
fect their assessment of nasal conditions. Likewise,
some of the symptoms, such as sleep disturbance,
can be caused by both conditions,13 so that it is diffi-
cult to weigh the contribution of asthma to the symp-
toms. Second, because of the nature of a cross-
sectional study selection of the subjects could have
potentially been biased, and the results presented
here reflect temporal but not long-term associations.
Third, the prevalence of nasal allergy in the preva-
lence is lower than those of other reports,14,15 sug-
gesting that diagnosing allergic rhinitis was missed in
a part of the patients, especially in those who have
mild nasal symptoms. This might have influenced the
study results.
Despite these limitations, the number of analyzed
subjects from multiple institutions still signifies the
findings of the study. Randomized prospective stud-
ies are preferred to validate the present findings fur-
ther.
Despite these methodological limitations, the re-
sults of the present study are noteworthy because an
intimate association of allergic rhinitis and asthma in
the light of the patients’ perceptions has been demon-
strated. Since nasal condition has a significant impact
on self-perception of asthma control and treatment
satisfaction, it should be monitored as closely as
asthma conditions to deliver optimal care for patients
with asthma complicated by allergic rhinitis.
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